Rodriguez-Martínez, Lorena
Bang, Holger
Regueiro, Cristina
Nuño, Laura
Triguero-Martinez, Ana
Peiteado, Diana
Ortiz, Ana M.
Villalba, Alejandro
Martinez-Feito, Ana
Balsa, Alejandro
Gonzalez-Alvaro, Isidoro
Gonzalez, Antonio
Funding for this research was provided by:
Axencia Galega de Innovación
Ministerio de Educación, Cultura y Deporte (FPU15/03434)
Instituto de Salud Carlos III (RD16/0012/0012, PI14/00442, RD16/0012/0014)
Article History
Received: 12 May 2020
Accepted: 18 September 2020
First Online: 6 November 2020
Competing interests
: Holger Bang is employee of the diagnostic company Orgentec Diagnostika. Alejandro Balsa has received grant/research support from: Abbvie, Pfizer, Novartis, BMS, Nordic, Sanofi; Consultant for: Abbvie, Pfizer, Novartis, BMS, Nordic, Sanofi, Sandoz, Lilly; Paid instructor for: Pfizer; Speakers bureau: Pfizer, Novartis, UCB, Nordic, Sanofi, Sandoz, Lilly. Isidoro Gonzalez-Alvaro has received personal fees from Lilly and Sanofi; personal fees and non-financial support from BMS, Abbvie, and Roche Laboratories; non-financial support from MSD, Pfizer and Novartis. Antonio Gonzalez has received research support and speaker fees from BMS. The other authors declare no financial interests that could create a potential conflict of interest or the appearance of a conflict of interest regarding this work.